Neurol. praxi. 2019;20(3):171-178 | DOI: 10.36290/neu.2019.110

Muscular dystrophy in childhood

MUDr. Jana Haberlová, Ph.D.
Neuromuskulární centrum Kliniky dětské neurologie 2. LF UK a FN Motol, Praha

Muscular dystrophies are a heterogeneous group of inherited rare disorders that is characterized by progressive muscular weakness and a dystrophic pattern in muscular biopsy. As these disorders are inherited, the first symptoms typically appear during childhood. In the last few years, mainly due to the new genetic possibilities, this area is changing. There is an increase of diagnostic clarity (in our Centre it is more than 90 %) and an improvement in symptomatic care; and due to this, an increase of life expectancy and quality of life. Now, there are the first possibilities of causal therapy. In the article there is a description of the most common type of muscular dystrophies in childhood, diagnostic tools and therapy.

Keywords: muscular dystrophy, childhood, limb girdle muscular dystrophy, facioscapulohumeral muscular dystrophy, congenitalmuscular dystrophy

Published: June 12, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Haberlová J. Muscular dystrophy in childhood. Neurol. praxi. 2019;20(3):171-178. doi: 10.36290/neu.2019.110.
Download citation

References

  1. Bao B, Maruyama R, Yokota T. Targeting mRNA for the treatment of facioscapulohumeral muscular dystrophy. Intractable & Rare Diseases Research. 2016; 5(3): 168-176. Go to original source... Go to PubMed...
  2. Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR, for the DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1-3. Lancet Neurol. 2018; 17(3): 251-267. Go to original source...
  3. Bönnemann CG, Wang ChW, Quijano-Roy S, Deconinck N, Bertini E, Ferreiro A, Muntoni F, Sewry C, Beroud Ch, Mathews KD, Moore SA, Bellini J, Rutkowski A, North KN, and Members of the International Standard of Care Committee for Congenital Muscular Dystrophies. Diagnostic approach to the congenital muscular dystrophies. Neuromuscular Disorders 24 (2014) 289-311. Go to original source... Go to PubMed...
  4. Klinge L, Eagle M, Haggerty ID, Roberts CE, Straub V, Bushby KM. Severe phenotype in infantile facioscapulohumeral muscular dystrophy. Neuromuscular Disorders 16 (2006) 553-558. Go to original source... Go to PubMed...
  5. Norwood F, de Visser M, Eymard B, Lochmuller H, Bushby K and Members of EFNS Guideline Task Force. EFNS guideline on diagnosis and management of limb girdle muscular dystrophies. European Journal of Neurology 2007; 14: 1305-1312. Go to original source...
  6. Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 2009; 132(Pt 11): 3175-3186. Go to original source... Go to PubMed...
  7. Rosales XQ, Tsao ChY. Childhood Onset of Limb-Girdle Muscular Dystrophy. Pediatric Neurology 46 (2012) 13-23. Go to original source...
  8. Straub V, Bertoli M. Where do we stand in trial readiness for autosomal recessive limb girdle muscular dystrophies?. Neuromuscular Disorders 26 (2016) 111-125. Go to original source... Go to PubMed...
  9. Straub V, Murphy A, Udd B on behalf of the LGMD workshop study group. 229th ENMC international workshop: Limb girdle muscular dystrophies - Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017. Neuromuscular Disorders 28 (2018) 702-710. Go to original source... Go to PubMed...
  10. Tawil R, Kissel JT, Heatwole C, Pandya S, Gronseth G, Benatar M; Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology. 2015; 85(4): 357-364. Go to original source... Go to PubMed...
  11. Vajsar J, Kraus J. Kongenitální svalové dystrofie. Neurol. praxi 2012; 13(4): 195-197.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.